LNP Characterization & Analytical Development Summit 2023

The LNP Characterization & Analytical Development Summit is a groundbreaking event that showcases the latest advancements in the field of lipid nanoparticle (LNP) technology. With recent breakthroughs from leading companies like Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio, the potential of LNPs has expanded beyond COVID-19 vaccines to include base editing, in vivo gene therapies, and RNA and DNA deliveries for a wide range of diseases.

In light of the updated nanomedicine guidance from the FDA and the increasing focus on precision medicine, it has become crucial for drug developers and manufacturers to refine and enhance their characterization and analytical capabilities. This summit serves as the ultimate platform for industry experts to come together and discuss the roadmap for LNP characterization, bioanalysis, reference materials, and potency assays throughout the product lifecycle.

Featuring participation from renowned companies such as Merck, Moderna, Pfizer, and many others, this summit offers a unique opportunity to delve into the intricacies of LNP technology. Attendees will gain invaluable insights, exchange knowledge, and acquire cutting-edge skills to optimize the encapsulation efficiency, stability, and scalability of DNA, RNA, saRNA, and mRNA payloads. The event aims to accelerate the development of next-generation therapeutics and foster breakthroughs in the field of LNP delivery vehicles in 2024 and beyond.

By attending the LNP Characterization & Analytical Development Summit, you will become part of a vibrant community that is dedicated to pushing the boundaries of LNP technology. Whether you are a researcher, scientist, drug developer, or industry professional, this summit promises to supercharge your knowledge and skills, allowing you to make a significant impact in your field. Join us and contribute to the advancement of LNP technology, unlocking its full therapeutic potential and revolutionizing the future of medicine.